AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (April 9, 2004). doi:10.1152/ajplung.00434.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/L438    most recent
00434.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quaglino, D.
Right arrow Articles by Baritussio, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quaglino, D.
Right arrow Articles by Baritussio, A.
Submitted on December 5, 2003
Accepted on March 25, 2004

Effects of metabolites and analogues of amiodarone on alveolar macrophages: structure-activity relationship

Daniela Quaglino1, Huy Riem Ha2, Elena Duner3, Daniela Bruttomesso4, Laurent Bigler5, Ferenc Follath2, Giuseppe Realdi3, Andrea Pettenazzo6, and Aldo Baritussio3*

1 Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy
2 Cardiovascular Therapy Research Laboratory, Department of Internal Medine, University Hospiatal of Zurich, Zurich, Switzerland
3 Clinica Medica 1, Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
4 Malattia del Metabolismo, Department of Clinical Medicine, University of Padova, Padova, Italy
5 Institute of Organic Chemistry, University of Zurich, Zurich, Switzerland
6 Department of Pediatrics, University of Padova, Padova, Italy

* To whom correspondence should be addressed. E-mail: aldo.baritussio{at}unipd.it.

Amiodarone, an antiarrhythmic drug toxic towards the lung, is metabolized through sequential modifications of the diethylaminoethoxy group to mono-N-desethylamiodarone (MDEA), di-Ndesetylamiodarone (DDEA) and amiodarone-EtOH (B2-O-EtOH), whose effects on lung cells are unclear. To clarify this, we exposed rabbit alveolar macrophages to analogues with different modifications of the diethylaminoethoxy group and then searched for biochemical signs of cell damage, formation of vacuoles and inclusion bodies and interference with the degradation of surfactant protein-A (SP-A), used as a tracer of the endocytic pathway. The substances studied included: MDEA, DDEA and B2-O-EtOH, analogues with different modifications of the diethylaminoethoxy group, fragments of the amiodarone molecule and the antiarrhythmic agents dronedarone (SR33589) and KB130015. We found the following: a) MDEA, DDEA and B2-O-EtOH rank in order of decreasing toxicity towards alveolar macrophages, indicating that dealkylation and deamination of the diethylaminoethoxy group represent important mechanisms of detoxification; b) dronedarone has greater and KB13001 has smaller toxicity than amiodarone towards alveolar macrophages; c) the benzofuran moiety, which is toxic to liver cells, is not directly toxic towards alveolar macrophages.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Breitenstein, S.F. Stampfli, G.G. Camici, A. Akhmedov, H.R. Ha, F. Follath, A. Bogdanova, T.F. Luscher, and F.C. Tanner
Amiodarone Inhibits Arterial Thrombus Formation and Tissue Factor Translation
Arterioscler. Thromb. Vasc. Biol., December 1, 2008; 28(12): 2231 - 2238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. Stadler, H. R. Ha, V. Ciminale, C. Spirli, G. Saletti, M. Schiavon, D. Bruttomesso, L. Bigler, F. Follath, A. Pettenazzo, et al.
Amiodarone Alters Late Endosomes and Inhibits SARS Coronavirus Infection at a Post-Endosomal Level
Am. J. Respir. Cell Mol. Biol., August 1, 2008; 39(2): 142 - 149.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
S. Salati, E. Bianchi, R. Zini, E. Tenedini, D. Quaglino, R. Manfredini, and S. Ferrari
Eosinophils, but not neutrophils, exhibit an efficient DNA repair machinery and high nucleolar activity
Haematologica, October 1, 2007; 92(10): 1311 - 1318.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
E. Shantsila, T. Watson, and G. Y. Lip
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias
Europace, September 1, 2007; 9(suppl_4): iv37 - iv44.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. M. Sanchez, D. Thomas, E. J. Gillespie, R. Damoiseaux, J. Rogers, J. P. Saxe, J. Huang, M. Manchester, and K. A. Bradley
Amiodarone and Bepridil Inhibit Anthrax Toxin Entry into Host Cells
Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2403 - 2411.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
K. M Dale and C M. White
Dronedarone: An Amiodarone Analog for the Treatment of Atrial Fibrillation and Atrial Flutter
Ann. Pharmacother., April 1, 2007; 41(4): 599 - 605.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. J. Tafreshi and J. Rowles
A Review of the Investigational Antiarrhythmic Agent Dronedarone
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 15 - 26.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.